Trump Secures Historic MFN Drug-Price Deal with AstraZeneca
#trump #astrazeneca #pfizer #drug_pricing
Trump announces a landmark MFN drug-price pact with AstraZeneca to reduce U.S. costs and align prices with wealthier nations.
AstraZeneca News and Analysis
About AstraZeneca
AstraZeneca plc is a leading British-Swedish multinational pharmaceutical and biotechnology company headquartered at the Cambridge Biomedical Campus in the UK. It specializes in developing and delivering innovative medicines across several critical therapeutic areas, including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation[1]. The company was formed in 1999 through the merger of two established entities: the Swedish Astra AB and the British Zeneca Group. Astra AB itself was founded in 1913 by doctors and apothecaries in Södertälje, Sweden, growing to become the country's largest pharmaceutical firm during the 20th century. Zeneca originated in 1993 when the pharmaceutical operations of Imperial Chemical Industries (ICI) in the UK were spun off. The merger combined Astra’s and Zeneca’s strengths, with headquarters established in the UK[1]. AstraZeneca has a robust global presence and a broad product portfolio that spans primary care, specialty care, and rare diseases. Its research and development efforts are concentrated in three major centers located in Cambridge (UK), Gothenburg (Sweden), and Gaithersburg (Maryland, US). The company has expanded through key acquisitions, including Cambridge Antibody Technology (2006), MedImmune (2007), Spirogen (2013), and Definiens (2014), which have enriched its biotechnological capabilities and product pipeline[1]. AstraZeneca is publicly traded with its primary listing on the London Stock Exchange and secondary listings on Nasdaq Stockholm and the American Nasdaq, where it is part of the Nasdaq-100 index. It ranks among the world’s largest pharmaceutical companies by market capitalization, reflecting its significant impact on global healthcare and ongoing innovation in drug development[1]. Notably, AstraZeneca has played a pivotal role in advancing treatments for cancer, cardiovascular diseases, and respiratory conditions, making it a prominent player at the intersection of business, biotechnolog
Latest right now for AstraZeneca